There are two primary mechanisms by which diabetes is felt to accelerate the course of CF pulmonary disease: compromised nutrition due to an insulin insufficient catabolic state, and the negative impact of hyperglycemia on lung inflammation and infection. This evidence concerns the gene INS and cystic fibrosis.